{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:00:05Z","timestamp":1781719205941,"version":"3.54.5"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"C","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Clostridium difficile<\/jats:italic>\n                      is one of the most common healthcare-associated infections. Pseudomembranous colitis is a serious complication of\n                      <jats:italic toggle=\"yes\">Clostridium difficile<\/jats:italic>\n                      infection (CDI) after septic surgery and antibacterial therapy. A sudden white blood cell (WBC) count increase and extremely high leucocytosis may be a predictor of a poor outcome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Presentation of case<\/jats:title>\n                    <jats:p>\n                      A 77 years old male was hospitalised because of lower leg osteomyelitis and was operated. He received antibacterial treatment with Cefazolin for three days and then developed a high WBC count. The course of the disease was fulminant, with a rapid increase in the WBC count up to 132,000\/mm\n                      <jats:sup>3<\/jats:sup>\n                      and a septic shock, and required cardiovascular and ventilatory support. The patient was started on intravenous Metronidazole (500 mg every eight hours) and oral Vancomycin (500 mg every six hours). The patient\u2019s condition gradually improved over a period of six days. Then a hyperthermia above 39 degrees Celsius, hypotension and painful abdominal bloating developed, and the WBC count peaked to 186,000\/mm\n                      <jats:sup>3<\/jats:sup>\n                      . The blood cultures were positive for\n                      <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic>\n                      . The patient died.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      In our case, we describe a community-onset, healthcare-facility-associated, severe CDI complicated by a blood stream infection. The administration of oral Vancomycin, which is highly active against the intestinal flora, could have been responsible for the persistence and overgrowth of\n                      <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Severe CDIs after orthopaedic surgery and antibacterial treatment complicated by the development of nosocomial infection significantly worsen the prognosis of the disease. Careful consideration of antibacterial therapy and early symptom recognition may help prevent catastrophic events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijscr.2020.12.018","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T17:54:23Z","timestamp":1607536463000},"page":"155-158","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Severe Clostridium difficile infection with extremely high leucocytosis complicated by a concomitant bloodstream infection caused by Klebsiella pneumoniae after osteomyelitis surgery"],"prefix":"10.1097","volume":"78","author":[{"given":"Iveta","family":"Golubovska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dace","family":"Vigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martins","family":"Malzubris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luize","family":"Raga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergejs","family":"Isajevs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksejs","family":"Miscuks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-35-20260114","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/cid\/cix947","article-title":"Risk of subsequent sepsis within 90 days after a hospital stay by type of antibiotic exposure","volume":"66","author":"Baggs","year":"2018","journal-title":"Clin. Infect. Dis"},{"key":"R2-35-20260114","doi-asserted-by":"crossref","first-page":"ofv113","DOI":"10.1093\/ofid\/ofv113","article-title":"Association between outpatient antibiotic prescribing practices and community-associated Clostridium difficile infection","volume":"2","author":"Dantes","year":"2015","journal-title":"Open Forum Infect. Dis"},{"key":"R3-35-20260114","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/IPC.0000000000000350","article-title":"Diagnosis and treatment of Clostridium difficile infection (CDI)","volume":"24","author":"Gerding","year":"2016","journal-title":"Infect. Dis. Clin. Pract. (Baltim. Md"},{"key":"R4-35-20260114","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/cid\/ciy461","article-title":"The challenges of tracking Clostridium difficile to its source in hospitalized patients","volume":"68","author":"O\u2019Hagan","year":"2019","journal-title":"Clin. Infect. Dis"},{"key":"R5-35-20260114","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin. Infect. Dis"},{"key":"R6-35-20260114","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejim.2017.10.015","article-title":"Epidemiology and risk factors for mortality in bloodstream infection by CP-Kp, ESBL-E, Candida and CDI: a single center retrospective study","volume":"48","author":"Corcione","year":"2018","journal-title":"Eur. J. Intern. Med"},{"key":"R7-35-20260114","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1128\/AAC.01927-15","article-title":"Risk factors and outcomes for bloodstream infections secondary to Clostridium difficile infection","volume":"60","author":"Falcone","year":"2016","journal-title":"Antimicrob. Agents Chemother"},{"key":"R8-35-20260114","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/1471-2334-14-475","article-title":"Severe community onset healthcare-associated Clostridium difficile infection complicated by carbapenemase producing Klebsiella pneumoniae bloodstream infection","volume":"14","author":"Giuliano","year":"2014","journal-title":"BMC Infect. Dis"},{"key":"R9-35-20260114","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/1471-2334-13-299","article-title":"A unique strain of community-acquired Clostridium difficile in severe complicated infection and death of a young adult","volume":"13","author":"Heslop","year":"2013","journal-title":"BMC Infect. Dis"},{"key":"R10-35-20260114","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.anaerobe.2017.06.020","article-title":"Is Clostridium difficile infection a risk factor for subsequent bloodstream infection?","volume":"48","author":"Ulrich","year":"2017","journal-title":"Anaerobe"},{"key":"R12-35-20260114","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijsu.2018.10.028","article-title":"The SCARE 2018 statement: updating consensus surgical CAse REport (SCARE) guidelines","volume":"60","author":"Agha","year":"2018","journal-title":"Int. J. Surg"},{"key":"R13-35-20260114","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1017\/ice.2019.109","article-title":"A national survey of testing and management of asymptomatic carriage of C. difficile","volume":"40","author":"Kutty","year":"2019","journal-title":"Infect. Control Hosp. Epidemiol"},{"key":"R14-35-20260114","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1093\/cid\/cis319","article-title":"Current status of Clostridium difficile infection epidemiology","volume":"55","author":"Lessa","year":"2012","journal-title":"Clin. Infect. Dis"},{"key":"R15-35-20260114","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.anaerobe.2017.08.012","article-title":"Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection","volume":"48","author":"Gomez","year":"2017","journal-title":"Anaerobe"},{"key":"R16-35-20260114","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.idcr.2017.03.012","article-title":"Clostridium difficile bacteremia: report of two cases in French hospitals and comprehensive review of the literature","volume":"8","author":"Doufair","year":"2017","journal-title":"IDCases"},{"key":"R17-35-20260114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2012.05.008","article-title":"Risk factors for mortality in Clostridium difficile infection in the general hospital population: a systematic review","volume":"82","author":"Bloomfield","year":"2012","journal-title":"J. Hosp. Infect"},{"key":"R18-35-20260114","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.anaerobe.2017.02.014","article-title":"Role of the leukocyte response in normal and immunocompromised host after Clostridium difficile infection","volume":"45","author":"Vargas","year":"2017","journal-title":"Anaerobe"}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261220312074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261220312074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2020.12.018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:49:32Z","timestamp":1768398572000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2020.12.018"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":17,"journal-issue":{"issue":"C","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2020.12.018","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}